| Dec 31,
2020 | Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 |
|---|
| Net earnings (loss) | -670 | -1,269 | 2,079 | 55 |
|---|
| Depreciation and amortization | 2,216 | 4,507 | 3,028 | 2,741 |
|---|
| Deferred income tax expense (benefit) | -213 | 676 | -26 | -387 |
|---|
| Litigation settlements and other contingencies, net | -101 | -324 | 2 | -87 |
|---|
| Loss from equity method investments | -48 | -62 | - | - |
|---|
| Loss (gain) on disposal of business | - | - | 1,754 | -240 |
|---|
| Share-based compensation expense | 79 | 111 | 116 | 181 |
|---|
| Other non-cash items | -366 | -412 | -434 | -595 |
|---|
| Accounts receivable | -79 | -59 | 240 | -79 |
|---|
| Inventories | 742 | 428 | 260 | 613 |
|---|
| Trade accounts payable | -83 | -70 | 170 | 315 |
|---|
| Income taxes | 4 | -700 | 25 | -77 |
|---|
| Other operating assets and liabilities, net | -46 | 667 | 618 | 415 |
|---|
| Net cash provided by operating activities | 1,232 | 3,017 | 2,953 | 2,800 |
|---|
| Cash (paid) received for acquisitions, net of cash acquired | -416 | -277 | - | 668 |
|---|
| Capital expenditures | 243 | 457 | 406 | 377 |
|---|
| Payments for product rights and other, net | 438 | 52 | 37 | 98 |
|---|
| Proceeds from sale of property, plant and equipment | 2 | 18 | 14 | 14 |
|---|
| Proceeds from Divestiture of Businesses | 20 | 97 | 1,950 | 364 |
|---|
| Purchase of marketable securities | 105 | 30 | 30 | 26 |
|---|
| Proceeds from the sale of marketable securities | 47 | 30 | 30 | 26 |
|---|
| Net cash (used in) provided by investing activities | -301 | -118 | 1,521 | -764 |
|---|
| Proceeds from issuance of long-term debt | 983 | 1,710 | 1,876 | 0 |
|---|
| Payments of long-term debt | 2,484 | 4,201 | 3,663 | 1,250 |
|---|
| Payments of financing fees | 2 | 7 | 2 | 1 |
|---|
| Change in short-term borrowings, net | 1,100 | 392 | -1,493 | 0 |
|---|
| Proceeds from Stock Options Exercised | 1 | - | - | - |
|---|
| Purchase of ordinary shares | - | - | - | 250 |
|---|
| Taxes paid related to net share settlement of equity awards | 8 | 17 | 17 | 38 |
|---|
| Contingent consideration payments | 49 | 29 | 19 | 8 |
|---|
| Cash dividends paid | - | 399 | 582 | 576 |
|---|
| Non-contingent payments for product rights | 143 | 456 | - | 10 |
|---|
| Issuance of common stock | - | - | 3 | 3 |
|---|
| Other items, net | -3 | -5 | 19 | -173 |
|---|
| Net cash used in financing activities | -606 | -3,012 | -3,878 | -2,302 |
|---|
| Effect on cash of changes in exchange rates | - | - | -39 | -2 |
|---|
| Net (decrease) increase in cash, cash equivalents and restricted cash | 359 | -144 | 556 | -269 |
|---|
| Common stock issued for the Combination | 10,728 | - | - | - |
|---|
| Income taxes | 324 | 642 | 735 | 571 |
|---|
| Interest | 555 | 685 | 643 | 612 |
|---|
| Income taxes | 324 | 642 | 735 | 571 |
|---|
| Interest | 555 | 685 | 643 | 612 |
|---|